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human osteoarthritis (OA) patients and several OA mice models such as
STR/ort, collagenase-induced arthritis and destabilization of the medial
meniscus (DMM) mice models. Intra-articular injection of recombinant IL-6
into mouse knee joint causes severe cartilage destruction. In addition,
neutralization of soluble IL-6 with anti-IL-6 antibody inhibits IL-1β- or
HIF-2α-induced MMP3 and MMP13 expression both in vitro and in vivo,
ans also blocks cartilage destruction.
Conclusions: Based on these observations, we conclude that IL-6 is a novel
target gene of HIF-2α and caused cartilage destruction by regulating MMP3
and MMP13 expression in mouse articular cartilage. Our data also suggest
that blockade of IL-6 inhibits cartilage destruction in several OA mice
models.
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Purpose: Acute chondrocyte death, which contributes to the progression of
post-traumatic osteoarthritis (PTOA), is in part due to sudden mechanical
insult-induced release of reactive oxygen species (ROS) from mitochon-
dria. Antioxidant treatment blocks these effects, but may have deleterious
effects on normal cartilage because ROS are involved in signaling and
metabolism. Though chondrocytes rely mainly on glycolysis to meet their
energy requirements, mitochondria might play an indirect role in ATP
production by regulating cellular redox balance. We hypothesized that in-
hibiting baseline oxidant production from mitochondrial electron transport
(MET) would signiﬁcantly hinder ATP synthesis. To test this, we measured
viability in addition to ATP and ROS production in bovine cartilage tissue
samples following treatment with rotenone, which acts to block complex I
(NADH oxidase) of the MET chain. Oligomycin, a complex V (ATP synthase)
inhibitor was used to evaluate the contribution of mitochondrial ATP
synthesis without inhibiting oxidant production. Effects on ATP production
and viability were compared with the effects of the glycolytic inhibitor
2-ﬂuoro-2-deoxy-D-glucose (2-F,G).
Methods: Tissue: Osteochondral explants were harvested from bovine me-
dial tibial plateaus and incubated in low glucose culture medium with 10%
serum.
Inhibitor Treatments: Samples were treated for 24 hours with either 2.5
μm rotenone, 4 μg/mL oligomycin, or 1 mM 2-ﬂuoro-2-deoxy-D-glucose
(2-F,G).
ATP Production: Immediately after a 24 hour treatment, 6-mm cartilage
plugs were harvested and placed into a cocktail of phosphatase inhibitors
(Sigma P5726). Samples were massed and placed into a boiling water bath
for 10 minutes to extract ATP. ATP levels in the supernatant were measured
using the Sigma FLAA ATP Bioluminescent assay kit and the 1450 MicroBeta
TriLux Microplate Scintillation and Luminescence Counter. (n≥3 explants)
Oxidant Production: Confocal microscopy was used to visualize the ﬂuores-
cent probes calcein AM and dihydroethidium (DHE). Samples were treated
for 4 hours with either 2.5 μm rotenone or 4 μg/mL oligomycin prior
to receiving a blunt impact (7 J/cm2) to the cartilage surface. Three sites
inside and outside the impact sites were imaged 1 hour after impact. (n≥3
explants)
Viability: Confocal microscopy was used to image the ﬂuorescent probes
calcein AM and ethidium homodimer-2 following 24 hour treatment the
metabolic inhibitors. (n≥3)
Statistical Analysis: A one-way ANOVA with a post hoc Holm-Sidek correc-
tion for multiple comparisons was used to compare treatment groups for
ATP content, viability, and DHE staining (p<0.05).
Results: 2-F,G and rotenone signiﬁcantly reduced ATP content (p<0.001),
whereas oligomycin showed no signiﬁcant effect (Figure 1). Rotenone
treatment, but not oligomycin treatment signiﬁcantly reduced ROS pro-
duction (p<0.001) (Figure 2). None of the inhibitors signiﬁcantly reduced
chondrocyte viability (Figure 3).
Conclusions: None of the drugs were overtly cytotoxic, indicating that
suppression of ATP synthesis was not due to loss of viability. The in-
hibition of chondrocyte mitochondrial ATP synthase by oligomycin had
little effect on ATP content, whereas the glycolysis inhibitor 2-F,G showed
dramatic inhibitory effects. This conﬁrmed that glycolysis is the primary
ATP source in cartilage. Unlike oligomycin, which failed to suppress ATP or




an ROS-mediated interaction between glycolysis and mitochondria. We
speculate that chondrocytes are under reductive stress in the low oxygen
environment of the joint, resulting in accumulation of the reduced form
of nicotinamide adenine dinucleotide (NADH). Under such conditions, ROS
released by mitochondria might support glycolysis by recycling NADH to
its oxidized form.
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Purpose: To characterize the biological quality and potential of chondro-
cytes from the dissected fragment.
Methods: In total, 20 patients with cartilage lesions in the knee were
involved in this study. Dissected fragments from 10 patients with typical
OCD were harvested at arthroscopy. A biopsy of cartilage from the in-
tercondylar notch was taken from the same joint and from 10 patients
with a traumatic full thickness cartilage defect as part of the autologous
chondrocyte implantation (ACI) procedure. Chondrocytes were isolated by
enzymatic digestion and expanded by subsequent primary cell culture.
Before and after cultivation, mRNA levels of collagen types I, -II, and -X
